Beta Bionics, Inc. Common Stock BBNX Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $30.21M-28.9% | $31.58M+3.8% | $38.49M+120% | $35.08M+169% | $42.45M+92.3% | ||
| $169.31M-10.4% | $187.55M+156% | $190.2M— | $214.65M— | $189.02M— | ||
| $15.75M+73.8% | $17.12M+42.7% | $11.54M— | $11.4M+332% | $9.06M+372% | ||
| $23.73M+50.8% | $21.72M+63.1% | $20.37M+419% | $17.32M+345% | $15.73M+554% | ||
| $247.99M-5.3% | $267.91M+102% | $270.03M— | $286.08M— | $261.92M— | ||
| $10.16M+84.2% | $8.6M+80.1% | $7.39M— | $6.47M— | $5.52M— | ||
| $304.42M-9.9% | $328.74M+120% | $330.05M— | $329.97M— | $338.02M— | ||
| $2.32M-32.9% | $5M+75.2% | $4.46M+4,108% | $3.42M+223% | $3.45M+742% | ||
| $3.35M+43.8% | $3.3M+77.3% | $2.99M— | $2.67M— | $2.33M— | ||
| $23.19M+40.6% | $30.92M+46.2% | $25.39M— | $19.49M— | $16.49M— | ||
| $33.17M+36.7% | $41.13M-44.1% | $35.29M— | $28.34M— | $24.27M— | ||
| $5K+25.0% | $4K+300% | $4K— | $4K— | $4K— | ||
| -$391.83M-20.4% | -$369.94M-24.7% | -$356.47M— | -$342.26M— | -$325.39M— | ||
| $271.25M-13.5% | $287.61M+217% | $294.76M+229% | $301.63M+236% | $313.75M+246% | ||
| $304.42M-9.9% | $328.74M+120% | $330.05M— | $329.97M— | $338.02M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Beta Bionics, Inc. Common Stock's total assets?
- Beta Bionics, Inc. Common Stock (BBNX) holds $304.4M in total assets, down 9.9% year over year.
- How much debt does Beta Bionics, Inc. Common Stock have?
- Beta Bionics, Inc. Common Stock carries $6.9M in total debt against $271.2M of shareholders' equity, a debt-to-equity ratio of 0.03.
- How much cash does Beta Bionics, Inc. Common Stock have?
- Beta Bionics, Inc. Common Stock holds $30.2M in cash and equivalents.
- Can Beta Bionics, Inc. Common Stock cover its short-term obligations?
- Its current ratio is 10.69 — current assets exceed current liabilities.
- Where does Beta Bionics, Inc. Common Stock's balance sheet data come from?
- Every line is extracted from Beta Bionics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
